Enroll
Ongoing
|
Webinar
|
Online
|
Ongoing
|
|
|
Lisa Chen, MD
David Ashkin, MD
Richard Menzies, MD
Andrew Vernon, MD, MHS
Payam Nahid, MD, MPH
Susan E. Dorman, MD
|
This is the 1st webinar in a 2-part series. This 90-minute webinar introduces the 2016 Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis and highlight the development process, the key changes in recommendations, and discuss the evidence supporting the changes. The didactic presentations will be followed by a discussion period with the ATS, CDC, and IDSA guidelines co-chairs.
Learning Objectives
Upon completion of this webinar, participants will be able to:
- Understand the process and rationale for the recommendations in the 2016 Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis and use this information to guide clinical decision-making
- Apply the new treatment guidelines in their own clinical practice, resulting in improved patient outcomes.
Webinar Materials: https://www.currytbcenter.ucsf.edu/trainings/2016-atscdcidsa-clinical-practice-guidelines-treatment-drug-susceptible-tuberculosis/materials
Keywords: TB, tuberculosis, TB disease, MTB, Mycobacterium tuberculosis, MTB complex